Epigenetic modification in liver fibrosis: Promising therapeutic direction with significant challenges ahead
Liver fibrosis, characterized by scar tissue formation, can ultimately result in liver failure. It's a major cause of morbidity and mortality globally, often associated with chronic liver diseases like hepatitis or alcoholic and non-alcoholic fatty liver diseases. However, current treatment opt...
Saved in:
Main Authors: | Runping Liu (Author), Yajing Li (Author), Qi Zheng (Author), Mingning Ding (Author), Huiping Zhou (Author), Xiaojiaoyang Li (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Flavonoids from Aurantii Fructus Immaturus and Aurantii Fructus: promising phytomedicines for the treatment of liver diseases
by: Jianzhi Wu, et al.
Published: (2020) -
Epigenetic Modification Mechanisms Involved in Inflammation and Fibrosis in Renal Pathology
by: Jose Luis Morgado-Pascual, et al.
Published: (2018) -
Transcriptotype-Driven Discovery of Apigenin as a Therapy against Cholestatic Liver Fibrosis: Through Inhibition of PANoptosis and Following Type-I Interferon Responses
by: Shuni Duan, et al.
Published: (2024) -
Integrative lipidomic and transcriptomic study unravels the therapeutic effects of saikosaponins A and D on non-alcoholic fatty liver disease
by: Xiaojiaoyang Li, et al.
Published: (2021) -
Advances in the study of emodin: an update on pharmacological properties and mechanistic basis
by: Qi Zheng, et al.
Published: (2021)